VIVOS THERAPEUTICS, INC. (VVOS) Gross profit 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) annual gross profit history from SEC filings — each fiscal year as reported.
$10.5MFY2025 · since FY2019: $8.7M → $10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.5M | +16.9% |
| FY2024 | $9.0M | +9.0% |
| FY2023 | $8.3M | -17.4% |
| FY2022 | $10.0M | -20.5% |
| FY2021 | $12.6M | +21.0% |
| FY2020 | $10.4M | +20.3% |
| FY2019 | $8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross marginVVOS Operating incomeVVOS Operating marginVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →